Clinical Trial Update: Feasibility Study of Urinary cfDNA Analysis as a Non-invasive Monitoring Tool in Patients With Prostate or Bladder Cancer

View source ↗

Summary

Feasibility study evaluating urinary cell-free DNA as a non-invasive monitoring tool in prostate cancer and bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Prostate Cancer

Snippet

Sponsor: Institut Cancerologie de l'Ouest | Conditions: Prostate Cancer, Bladder Cancer | Status: NOT_YET_RECRUITING